Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$0.53 - $0.84 $4,435 - $7,029
8,369 Added 44.82%
27,043 $16,000
Q4 2023

Feb 26, 2024

BUY
$0.37 - $0.75 $6,909 - $14,005
18,674 New
18,674 $11,000
Q2 2022

Aug 09, 2022

BUY
$2.16 - $6.36 $31,734 - $93,441
14,692 New
14,692 $32,000

Others Institutions Holding XCUR

About EXICURE, INC.


  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $55.5M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.